We are live on ! Find out more
JSC

Jackson Square Capital Portfolio holdings

AUM $719M
1-Year Est. Return 144.18%
This Fund
S&P 500
This Quarter Est. Return
-1.76%
1 Year Est. Return
+144.18%
3 Year Est. Return
+415.93%
5 Year Est. Return
+613.77%
10 Year Est. Return
AUM
$205M
AUM Growth
-$31.7M
Cap. Flow
-$25.1M
Cap. Flow %
-12.26%
Top 10 Hldgs %
37.46%
Holding
155
New
17
Increased
33
Reduced
54
Closed
33

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$4.43M
2
GFS icon
GlobalFoundries
GFS
+$2.27M
3
ADI icon
Analog Devices
ADI
+$1.46M
4
TGT icon
Target
TGT
+$1.34M
5
SYK icon
Stryker
SYK
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 32.36%
2 Healthcare 21.13%
3 Energy 9.75%
4 Consumer Discretionary 9.44%
5 Financials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJRD
151
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-5,569
Closed -$226K
FRC
152
DELISTED
First Republic Bank
FRC
-1,649
Closed -$238K
ACC
153
DELISTED
American Campus Communities, Inc.
ACC
-3,556
Closed -$229K
SRRA
154
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-101,000
Closed -$5.55M
SIVB
155
DELISTED
SVB Financial Group
SIVB
-861
Closed -$340K

Similar funds

Jackson Square Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Jackson Square Capital held 155 positions worth $205M, down 13% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jackson Square Capital withdrew a net $25.1M in Q3 2022, closing 33 positions and reducing 54 holdings. Its most notable exit was Sierra Oncology, Inc. Common Stock, an estimated $5.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Jackson Square Capital opened a new position in Synopsys worth $4M.

  • Jackson Square Capital's largest Q3 2022 buy was Synopsys: 13,078 shares worth $4M.
  • Jackson Square Capital added most to Analog Devices in Q3 2022, an estimated $1.46M increase.
  • Jackson Square Capital's biggest Q3 2022 reduction was Marathon Oil Corporation, cutting an estimated $2.66M.
  • Jackson Square Capital fully exited Sierra Oncology, Inc. Common Stock in Q3 2022, selling an estimated $5.55M.
  • Jackson Square Capital's ten largest holdings make up 37% of its $205M portfolio in Q3 2022.
  • Jackson Square Capital opened 17 new positions and closed 33 in Q3 2022.
  • Jackson Square Capital's portfolio value fell 13% quarter-over-quarter to $205M.

Based on Jackson Square Capital's 13F filing for Q3 2022, filed 13 Oct 2022.